Department of Urology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Nephrol Dial Transplant. 2012 Oct;27(10):3799-806. doi: 10.1093/ndt/gfs360. Epub 2012 Aug 17.
Recent studies have identified T cells and natural killer T (NKT) cells as important mediators in renal ischemia-reperfusion (I/R) injury. The recruitment of these cells is induced by chemotaxis factors. We investigated the effects of blocking CXCR3 and CCR5 by an antagonist (TAK) using a rat renal I/R injury model.
The Sprague-Dawley rats were either subjected to sham operation or left renal occlusion for 45 min followed by reperfusion and contralateral nephrectomy. The control or TAK groups were, respectively, injected phosphate-buffered saline or TAK at 30 min prior to clamp. Serum creatinine, tubular injury, chemokines expression and infiltrating cells were assessed.
TAK treatment significantly suppressed the elevation in serum creatinine (sham 0.40 ± 0.05 mg/dL, control 2.86 ± 0.67 mg/dL, TAK 1.60 ± 0.73 mg/dL) and resulted in a lower tubular injury score compared with the control group (sham 0, control 4.8 ± 0.3, TAK 3.3 ± 1). The mRNA expression of chemokines that bind to CXCR3 and CCR5 in the post-ischemic kidneys was elevated at 1 h after reperfusion in each group. Moreover, the infiltration of CD4+ T cells and CD8+ NKT cells in the control group increased compared with the sham group and TAK injection significantly suppressed the number of CD4+ T cells (sham 13.5 ± 3.5 × 10(4) cells, control 28.9 ± 15.4 × 10(4) cells, TAK 11.8 ± 3.5 × 10(4) cells) and the number of CD8+ NKT cells (sham 11.7 ± 5.4 × 10(4) cells, control 30.1 ± 8.6 × 10(4) cells, TAK 11.8 ± 2.9 × 10(4) cells).
These findings suggest that the blocking of CXCR3 and CCR5 suppress the infiltration of T cells and NKT cells and have a protective effect on kidneys that are injured by I/R.
最近的研究表明 T 细胞和自然杀伤 T(NKT)细胞是肾缺血再灌注(I/R)损伤的重要介质。这些细胞的募集是由趋化因子诱导的。我们使用大鼠肾 I/R 损伤模型研究了用拮抗剂(TAK)阻断 CXCR3 和 CCR5 的效果。
Sprague-Dawley 大鼠行假手术或左肾夹闭 45min 后再灌注并对侧肾切除。对照组或 TAK 组分别于夹闭前 30min 注射磷酸盐缓冲液或 TAK。评估血清肌酐、肾小管损伤、趋化因子表达和浸润细胞。
TAK 治疗显著抑制了血清肌酐的升高(假手术组 0.40±0.05mg/dL,对照组 2.86±0.67mg/dL,TAK 组 1.60±0.73mg/dL),与对照组相比,肾小管损伤评分也较低(假手术组 0,对照组 4.8±0.3,TAK 组 3.3±1)。各组缺血再灌注后 1h,与缺血再灌注后肾脏结合 CXCR3 和 CCR5 的趋化因子 mRNA 表达升高。此外,与假手术组相比,对照组 CD4+T 细胞和 CD8+NKT 细胞浸润增加,TAK 注射显著抑制 CD4+T 细胞数量(假手术组 13.5±3.5×10^4 个细胞,对照组 28.9±15.4×10^4 个细胞,TAK 组 11.8±3.5×10^4 个细胞)和 CD8+NKT 细胞数量(假手术组 11.7±5.4×10^4 个细胞,对照组 30.1±8.6×10^4 个细胞,TAK 组 11.8±2.9×10^4 个细胞)。
这些发现表明,阻断 CXCR3 和 CCR5 抑制了 T 细胞和 NKT 细胞的浸润,并对 I/R 损伤的肾脏具有保护作用。